David Y. Liu
Geen lopende functies
Vermogen: 4 M $ op 31-03-2024
Profiel
David Y.
Liu was the founder of Trenovus, Inc. (founded in 2010) where he held the title of Chief Operating Officer from 2010 to 2012.
He previously worked at Scios, Inc. from 1992 to 2002 as Director-Inflammation Research and at FibroGen, Inc. from 2002 to 2010 as Vice President-Research.
Dr. Liu also worked at Harvard Medical School from 1976 to 1986 as Assistant Professor-Medicine Department.
He is currently the Chief Research & Development Strategy Officer at Protagonist Therapeutics, Inc. (since 2013).
Dr. Liu holds a doctorate degree from Michigan State University and an undergraduate degree from The University of Chicago.
Bekende belangen in openbare bedrijven
Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
---|---|---|---|---|
15-03-2023 | 144 687 ( 0.25% ) | 4 M $ | 31-03-2024 |
Eerdere bekende functies van David Y. Liu
Bedrijven | Functie | Einde |
---|---|---|
PROTAGONIST THERAPEUTICS, INC. | Chief Tech/Sci/R&D Officer | 01-01-2023 |
Trenovus, Inc. | Founder | 01-01-2012 |
FIBROGEN, INC. | Chief Tech/Sci/R&D Officer | 01-01-2010 |
Scios, Inc.
Scios, Inc. Pharmaceuticals: MajorHealth Technology Scios Inc. developed, manufactured, and commercialized pharmaceuticals for conditions such as cardiovascular and inflammatory diseases. The company was founded in 1981 and was headquartered in Sunnyvale, CA. | Corporate Officer/Principal | 01-01-2002 |
Harvard Medical School | Corporate Officer/Principal | 01-01-1986 |
Opleiding van David Y. Liu
Michigan State University | Doctorate Degree |
The University of Chicago | Undergraduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Beursgenoteerde bedrijven | 2 |
---|---|
FIBROGEN, INC. | Health Technology |
PROTAGONIST THERAPEUTICS, INC. | Health Technology |
Bedrijven in privébezit | 2 |
---|---|
Scios, Inc.
Scios, Inc. Pharmaceuticals: MajorHealth Technology Scios Inc. developed, manufactured, and commercialized pharmaceuticals for conditions such as cardiovascular and inflammatory diseases. The company was founded in 1981 and was headquartered in Sunnyvale, CA. | Health Technology |
Trenovus, Inc. |